EMA: No restrictions on AstraZeneca vaccination

In contrast to the Standing Vaccination Commission (STIKO), the European Medicines Agency (EMA) refrains from an age limit for the corona vaccination from AstraZeneca. In contrast to the risk of dying from a corona infection, the risk of sinus vein thrombosis is very low. Contrary to previous statements by an EMA representative, there is said to be no causal connection between the possible side effects and the vaccination.

In Germany, the vaccine is currently only recommended for people over the age of 60, since the sinus vein thrombosis and pulmonary embolism that have occurred so far have mostly occurred in younger women. The vaccine is only given to younger people on recommendation and at their own risk.

Nations are free to continue giving the vaccine, to stop vaccination, or to limit the age group of those who can be vaccinated.

The EMA states that it will continue to monitor the vaccine and will continue to analyze the data as the vaccination progresses. So far, however, there are no specific risk factors. However, warnings about the possibility of side effects that have occurred so far should be included.